Retreversine structure
|
Common Name | Retreversine | ||
|---|---|---|---|---|
| CAS Number | 1028332-91-3 | Molecular Weight | 393.485 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 571.9±60.0 °C at 760 mmHg | |
| Molecular Formula | C21H27N7O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 299.7±32.9 °C | |
Use of RetreversineRetreversine is an inactive control for Reversine. Reversine is a novel class of ATP-competitive Aurora kinase inhibitor[1]. |
| Name | N2-Cyclohexyl-N6-[4-(4-morpholinyl)phenyl]-1H-purine-2,6-diamine |
|---|---|
| Synonym | More Synonyms |
| Description | Retreversine is an inactive control for Reversine. Reversine is a novel class of ATP-competitive Aurora kinase inhibitor[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 571.9±60.0 °C at 760 mmHg |
| Molecular Formula | C21H27N7O |
| Molecular Weight | 393.485 |
| Flash Point | 299.7±32.9 °C |
| Exact Mass | 393.227722 |
| PSA | 94.22000 |
| LogP | 0.56 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.740 |
| N-Cyclohexyl-N-[4-(4-morpholinyl)phenyl]-1H-purine-2,6-diamine |
| 1H-Purine-2,6-diamine, N-cyclohexyl-N-[4-(4-morpholinyl)phenyl]- |